Authors:
Sculpher, MJ
Poole, L
Cleland, J
Drummond, M
Armstrong, PW
Horowitz, JD
Massie, BM
Poole-Wilson, PA
Ryden, L
Citation: Mj. Sculpher et al., Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study, EUR J HE FA, 2(4), 2000, pp. 447-454
Citation: Mj. Sculpher et Bj. O'Brien, Income effects of reduced health and health effects of reduced income: Implications for health-state valuation, MED DECIS M, 20(2), 2000, pp. 207-215
Citation: Bj. O'Brien et Mj. Sculpher, Building uncertainty into cost-effectiveness rankings - Portfolio risk-return tradeoffs and implications for decision rules, MED CARE, 38(5), 2000, pp. 460-468
Citation: Dm. Gibb et al., Costs and benefits to the mother of antenatal HIV testing: estimates from simulation modelling, AIDS, 13(12), 1999, pp. 1569-1576